IN192750B - - Google Patents

Info

Publication number
IN192750B
IN192750B IN1170DE2000A IN192750B IN 192750 B IN192750 B IN 192750B IN 1170DE2000 A IN1170DE2000 A IN 1170DE2000A IN 192750 B IN192750 B IN 192750B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Deepak Murpani
Rajiv Malik
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Priority to IN1170DE2000 priority Critical patent/IN192750B/en
Priority to EP01270300A priority patent/EP1343481A4/en
Priority to AU2002220968A priority patent/AU2002220968A1/en
Priority to PCT/IB2001/002354 priority patent/WO2002047607A2/en
Publication of IN192750B publication Critical patent/IN192750B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Preparation (AREA)
IN1170DE2000 2000-12-15 2000-12-15 IN192750B (lt)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IN1170DE2000 IN192750B (lt) 2000-12-15 2000-12-15
EP01270300A EP1343481A4 (en) 2000-12-15 2001-12-07 PROCESS FOR THE PREPARATION OF A QUICKLY SOLUBLE DOSAGE FORM
AU2002220968A AU2002220968A1 (en) 2000-12-15 2001-12-07 Process for the preparation of a fast dissolving dosage form
PCT/IB2001/002354 WO2002047607A2 (en) 2000-12-15 2001-12-07 Process for the preparation of a fast dissolving dosage form

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1170DE2000 IN192750B (lt) 2000-12-15 2000-12-15

Publications (1)

Publication Number Publication Date
IN192750B true IN192750B (lt) 2004-05-15

Family

ID=11097139

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1170DE2000 IN192750B (lt) 2000-12-15 2000-12-15

Country Status (4)

Country Link
EP (1) EP1343481A4 (lt)
AU (1) AU2002220968A1 (lt)
IN (1) IN192750B (lt)
WO (1) WO2002047607A2 (lt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
KR100503949B1 (ko) * 2003-04-28 2005-07-26 주식회사유한양행 염산 온단세트론의 쓴맛을 효과적으로 은폐한 경구용 구강속붕해정 조성물
FR2858556B1 (fr) * 2003-08-06 2006-03-10 Galenix Innovations Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation
EP1510208A1 (en) 2003-08-22 2005-03-02 Fournier Laboratories Ireland Limited Pharmaceutical composition comprising a combination of metformin and statin
WO2005062722A2 (en) * 2003-11-21 2005-07-14 Sun Pharmaceutical Industries Limited Fexofenadine containing pharmaceutical formulation
US20090060983A1 (en) * 2007-08-30 2009-03-05 Bunick Frank J Method And Composition For Making An Orally Disintegrating Dosage Form
EP2044929A1 (en) * 2007-10-04 2009-04-08 Laboratorios del Dr. Esteve S.A. Oral fast distintegrating tablets
AU2008318851B2 (en) 2007-10-31 2014-04-17 Mcneil-Ppc, Inc. Orally disintegrated dosage form
DE102008047910A1 (de) 2008-09-19 2010-03-25 Molkerei Meggle Wasserburg Gmbh & Co. Kg Tablettierhilfsstoff auf Laktose- und Cellulosebasis
US8784781B2 (en) 2009-09-24 2014-07-22 Mcneil-Ppc, Inc. Manufacture of chewing gum product with radiofrequency
US20110318411A1 (en) 2010-06-24 2011-12-29 Luber Joseph R Multi-layered orally disintegrating tablet and the manufacture thereof
US8581001B2 (en) 2010-04-16 2013-11-12 Codman & Shurtleff Metformin-cysteine prodrug
US9119793B1 (en) 2011-06-28 2015-09-01 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for doxycycline
CN102258497B (zh) * 2011-08-18 2013-01-09 海南良方医药有限公司 一种拉米夫定片剂组合物及其制备方法
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
US9233491B2 (en) 2012-05-01 2016-01-12 Johnson & Johnson Consumer Inc. Machine for production of solid dosage forms
US10842802B2 (en) 2013-03-15 2020-11-24 Medicis Pharmaceutical Corporation Controlled release pharmaceutical dosage forms
CN103432091A (zh) * 2013-09-13 2013-12-11 钟术光 一种性能改善的片剂及其制备方法
MX368159B (es) 2014-01-10 2019-09-20 Johnson & Johnson Consumer Inc Proceso para elaborar tabletas con el uso de radiofrecuencia y partículas disipativas revestidas.
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
CN113453662A (zh) 2019-02-22 2021-09-28 康特伦英国斯温顿捷迪斯有限公司 储存期间药物颗粒包衣材料的团聚最小化以稳定化药物产品的崩解时间
GB2597577B (en) 2019-02-22 2023-09-20 Catalent Uk Swindon Zydis Ltd Minimizing agglomeration, aeration, and preserving the coating of pharmaceutical compositions comprising ibuprofen
US11179331B1 (en) 2020-04-21 2021-11-23 Cure Pharmaceutcai Holding Corp Oral soluble film containing sildenafil citrate
ES2929818T3 (es) 2020-05-18 2022-12-02 Orexo Ab Nueva composición farmacéutica para la administración de fármacos
EP4236921A1 (en) 2021-11-25 2023-09-06 Orexo AB Pharmaceutical composition comprising adrenaline

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0166440A3 (en) * 1984-06-28 1987-06-03 THE PROCTER & GAMBLE COMPANY Antacid composition
US4946684A (en) * 1989-06-20 1990-08-07 American Home Products Corporation Fast dissolving dosage forms
ATE208615T1 (de) * 1993-07-09 2001-11-15 Scherer Corp R P Verfahren zur herstellung von gefriergetrockneten arzneistoffdosierungsformen
US5622719A (en) * 1993-09-10 1997-04-22 Fuisz Technologies Ltd. Process and apparatus for making rapidly dissolving dosage units and product therefrom
GB2293099A (en) * 1994-09-15 1996-03-20 Mailway Packaging Group Ltd Drug formulation
TR199802068T2 (xx) * 1996-04-16 2000-01-21 Novartis Consumer Health S.A. H�zl� b�l�nen oral doz formu.
AU2640599A (en) * 1998-02-26 1999-09-15 Banyu Pharmaceutical Co., Ltd. An orally disintegrating composition and its manufacturing method
GT199900061A (es) * 1998-05-15 2000-10-14 Pfizer Formulaciones farmaceuticas.

Also Published As

Publication number Publication date
WO2002047607A3 (en) 2003-03-20
WO2002047607A2 (en) 2002-06-20
AU2002220968A1 (en) 2002-06-24
EP1343481A4 (en) 2004-03-17
EP1343481A2 (en) 2003-09-17

Similar Documents

Publication Publication Date Title
BE2012C026I2 (lt)
BE2010C009I2 (lt)
AR028236A3 (lt)
IN192750B (lt)
BRPI0003419A (lt)
CN3141005S (lt)
CN3150564S (lt)
AU2000280388A8 (lt)
CN3141406S (lt)
CL2006000179A1 (lt)
CN3133795S (lt)
CN3133951S (lt)
CN3134543S (lt)
AU2000271150A8 (lt)
CN3135489S (lt)
CN3135640S (lt)
CN3136792S (lt)
CN3137601S (lt)
CN3138983S (lt)
CN3139026S (lt)
CN3139842S (lt)
CN3140016S (lt)
CN3142146S (lt)
YU43900A (lt)
CN3141006S (lt)